Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A06884 | 32710880 | Arch Biochem Biophys | Eicosapentaenoic acid-containing polar lipids from seaweed Susabinori (Pyropia yezoensis) alleviate hepatic steatosis in obese db/db mice. | 2020 | Details |
A06885 | 32710621 | Nucleic Acids Res | Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH. | 2020 | Details |
A06886 | 32710190 | Diabetologia | Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes. | 2020 | Details |
A06887 | 32709942 | Sci Rep | Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction. | 2020 | Details |
A06888 | 32708435 | Nutrients | Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study. | 2020 | Details |
A06889 | 32708059 | Biomedicines | Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH. | 2020 | Details |
A06890 | 32708036 | Nutrients | The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
A06891 | 32707957 | Nutrients | Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study. | 2020 | Details |
A06892 | 32707340 | Clin Gastroenterol Hepatol | Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. | 2020 | Details |
A06893 | 32707225 | J Hepatol | aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. | 2020 | Details |
A06895 | 32706931 | Liver Int | Factors independently associated with cardiorespiratory fitness in patients with non-alcoholic fatty liver disease. | 2020 | Details |
A06896 | 32706083 | Eur Rev Med Pharmacol Sci | A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease. | 2020 | Details |
A06897 | 32706078 | Eur Rev Med Pharmacol Sci | Mediterranean diet and the prevention of non-alcoholic fatty liver disease: results from a case-control study. | 2020 | Details |
A06898 | 32705733 | J Neuroimaging | Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis. | 2020 | Details |
A06899 | 32705262 | Mol Med Rep | Expression of Notch family is altered in non‑alcoholic fatty liver disease. | 2020 | Details |
A06900 | 32705195 | Mol Med Rep | Trimetazidine improves hepatic lipogenesis and steatosis in non‑alcoholic fatty liver disease via AMPK‑ChREBP pathway. | 2020 | Details |
A06901 | 32704576 | Endocrinol Diabetes Metab | Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review. | 2020 | Details |
A06902 | 32704556 | Endocrinol Diabetes Metab | Noninvasive monitoring of liver fat during treatment with GLP-1 analogues and SGLT-2 inhibitors in a real-world setting. | 2020 | Details |
A06903 | 32702591 | Phytomedicine | The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism. | 2020 | Details |
A06904 | 32702499 | Ann Hepatol | STAT3: A key regulator in liver fibrosis. | 2020 | Details |
A06906 | 32702444 | Life Sci | A tRNA-derived fragment (tRF-3001b) aggravates the development of nonalcoholic fatty liver disease by inhibiting autophagy. | 2020 | Details |
A06908 | 32701508 | JCI Insight | Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. | 2020 | Details |
A06909 | 32700545 | Biol Res Nurs | Oral Probiotic Bifidobacterium Longum Supplementation Improves Metabolic Parameters and Alters the Expression of the Renin-Angiotensin System in Obese Mice Liver. | 2020 | Details |
A06910 | 32700500 | Minerva Gastroenterol Dietol | Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores. | 2020 | Details |
A06911 | 32700499 | Minerva Gastroenterol Dietol | Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease. | 2020 | Details |
A06912 | 32699301 | Sci Rep | Hyperglycemia-stimulating diet induces liver steatosis in sheep. | 2020 | Details |
A06913 | 32699233 | Sci Rep | MCD diet-induced steatohepatitis generates a diurnal rhythm of associated biomarkers and worsens liver injury in Klf10 deficient mice. | 2020 | Details |
A06914 | 32699106 | BMJ Open Diabetes Res Care | Hepatic fat is a stronger correlate of key clinical and molecular abnormalities than visceral and abdominal subcutaneous fat in youth. | 2020 | Details |
A06915 | 32698692 | United European Gastroenterol J | Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. | 2020 | Details |
A06916 | 32698306 | Int J Environ Res Public Health | Association of Genetic and Environmental Factors with Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. | 2020 | Details |
A06917 | 32698101 | Growth Horm IGF Res | Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression. | 2020 | Details |
A06918 | 32698063 | Int J Biol Macromol | Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. | 2020 | Details |
A06919 | 32698042 | Cell Mol Gastroenterol Hepatol | Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes. | 2020 | Details |
A06921 | 32697871 | Aliment Pharmacol Ther | Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination. | 2020 | Details |
A06924 | 32696189 | Metab Brain Dis | Melatonin regulates neurodegenerative complications associated with NAFLD via enhanced neurotransmission and cellular integrity: a correlational study. | 2020 | Details |
A06925 | 32696080 | Clin Res Cardiol | NAFLD and cardiovascular diseases: a clinical review. | 2020 | Details |
A06926 | 32695968 | JHEP Rep | New frontiers in liver resection for hepatocellular carcinoma. | 2020 | Details |
A06927 | 32695965 | JHEP Rep | Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD. | 2020 | Details |
A06928 | 32695733 | Can J Gastroenterol Hepatol | Verification of the Nutritional and Dietary Factors Associated with Skeletal Muscle Index in Japanese Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A06930 | 32694843 | Nat Metab | Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity. | 2019 | Details |
A06932 | 32694791 | Nat Metab | The small intestine shields the liver from fructose-induced steatosis. | 2020 | Details |
A06933 | 32694734 | Nat Metab | Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. | 2020 | Details |
A06934 | 32694515 | Sci Rep | The food contaminant deoxynivalenol provokes metabolic impairments resulting in non-alcoholic fatty liver (NAFL) in mice. | 2020 | Details |
A06936 | 32694178 | Gut | Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. | 2020 | Details |
A06938 | 32692879 | Mol Nutr Food Res | Inflammatory Diseases and Vitamin E-What Do We Know and Where Do We Go? | 2020 | Details |
A06941 | 32691524 | Obes Rev | Diet-induced rodent models of obesity-related metabolic disorders-A guide to a translational perspective. | 2020 | Details |
A06942 | 32691411 | Lipids | Alteration of Serum Phospholipid n-6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross-Sectional Study. | 2020 | Details |
A06944 | 32690594 | J Lipid Res | Depletion of adipocyte sphingosine kinase 1 leads to cell hypertrophy, impaired lipolysis, and nonalcoholic fatty liver disease. | 2020 | Details |
A06945 | 32690320 | Obes Res Clin Pract | Influence of LGALS3 and PNPLA3 genes in non-alcoholic steatohepatitis (NASH) in patients undergone bariatric surgery. | 2020 | Details |
A06946 | 32690265 | Bioorg Med Chem | Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL). | 2020 | Details |
A06947 | 32690183 | Clin Nutr ESPEN | A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity. | 2020 | Details |
A06948 | 32690182 | Clin Nutr ESPEN | Non-alcoholic fatty liver disease (NAFLD) among underweight adults. | 2020 | Details |
A06949 | 32690164 | Clin Nutr ESPEN | Effect of lifestyle modification education based on health belief model in overweight/obese patients with non-alcoholic fatty liver disease: A parallel randomized controlled clinical trial. | 2020 | Details |
A06950 | 32690054 | BMC Public Health | Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? | 2020 | Details |
A06951 | 32688339 | Endocr Connect | FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation. | 2020 | Details |
A06952 | 32688217 | J Nutr Biochem | Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. | 2020 | Details |
A06953 | 32687983 | Environ Toxicol Pharmacol | Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance. | 2020 | Details |
A06954 | 32687673 | Pediatr Int | Pediatric non-alcoholic fatty liver disease predicted by anthropometric values through transient elastography. | 2021 | Details |
A06955 | 32687428 | Autophagy | Hepatic peroxisomal β-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation. | 2020 | Details |
A06956 | 32687365 | J Med Chem | Design and Structural Optimization of Dual FXR/PPARδ Activators. | 2020 | Details |
A06957 | 32687159 | J Clin Endocrinol Metab | Sex-Specific Metabolite Biomarkers of NAFLD in Youth: A Prospective Study in the EPOCH Cohort. | 2020 | Details |
A06958 | 32686578 | Expert Opin Emerg Drugs | Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists. | 2020 | Details |
A06959 | 32686456 | Rev Esp Enferm Dig | What may GLP1 receptor agonists contribute to the treatment of patients with non-alcoholic fatty liver disease? | 2020 | Details |
A06960 | 32685988 | J Cancer Res Clin Oncol | Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas. | 2020 | Details |
A06961 | 32685936 | Explor Med | Nonalcoholic fatty liver disease and portal hypertension. | 2020 | Details |
A06962 | 32685690 | Hepatoma Res | Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma. | 2020 | Details |
A06963 | 32685107 | World J Hepatol | Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population. | 2020 | Details |
A06964 | 32684985 | Diabetol Metab Syndr | NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. | 2020 | Details |
A06965 | 32684739 | World J Gastroenterol | Medications in type-2 diabetics and their association with liver fibrosis. | 2020 | Details |
A06966 | 32684526 | Endocr J | Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. | 2020 | Details |
A06967 | 32684060 | Scand J Gastroenterol | Biomarkers of liver fibrosis: prospective comparison of multimodal magnetic resonance, serum algorithms and transient elastography. | 2020 | Details |
A06968 | 32683952 | Am J Physiol Gastrointest Liver Physiol | Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease. | 2020 | Details |
A06969 | 32683859 | Anal Chem | High-Selectivity Fluorescent Reporter toward Peroxynitrite in a Coexisting Nonalcoholic Fatty Liver and Drug-Induced Liver Diseases Model. | 2020 | Details |
A06970 | 32683103 | Clin Gastroenterol Hepatol | Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
A06971 | 32683094 | Ann Hepatol | Cerebral hemodynamics in the non-alcoholic fatty liver. | 2020 | Details |
A06972 | 32682086 | Ann Hepatol | Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis. | 2020 | Details |
A06973 | 32682050 | J Hepatol | Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view. | 2020 | Details |
A06974 | 32681291 | Obes Surg | 1-Year Follow-up of Single Anastomosis Sleeve Ileal (SASI) Bypass in Morbid Obese Patients: Efficacy and Concerns. | 2020 | Details |
A06975 | 32680977 | Aging (Albany NY) | Co-exposure to multi-walled carbon nanotube and lead ions aggravates hepatotoxicity of nonalcoholic fatty liver via inhibiting AMPK/PPARγ pathway. | 2020 | Details |
A06976 | 32679761 | Biomolecules | Untargeted Profiling of Bile Acids and Lysophospholipids Identifies the Lipid Signature Associated with Glycemic Outcome in an Obese Non-Diabetic Clinical Cohort. | 2020 | Details |
A06977 | 32679195 | Arch Biochem Biophys | (-)-Epicatechin and the comorbidities of obesity. | 2020 | Details |
A06978 | 32679144 | Life Sci | Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease. | 2020 | Details |
A06979 | 32677717 | Diabetes Metab Res Rev | NAFLD in type 2 diabetes mellitus: Still many challenging questions. | 2020 | Details |
A06980 | 32677680 | Clin Sci (Lond) | Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis. | 2020 | Details |
A06981 | 32674529 | Clin Mol Hepatol | Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. | 2020 | Details |
A06982 | 32674425 | Nutrients | Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. | 2020 | Details |
A06983 | 32674154 | J Appl Lab Med | Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis. | 2020 | Details |
A06984 | 32673798 | Mol Metab | Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis. | 2020 | Details |
A06985 | 32671772 | Adv Exp Med Biol | Autophagy and Liver Diseases. | 2020 | Details |
A06986 | 32671767 | Adv Exp Med Biol | Autophagy and Obesity and Diabetes. | 2020 | Details |
A06987 | 32671584 | Dig Dis Sci | Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis. | 2020 | Details |
A06988 | 32671116 | J Immunol Res | Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes Activity. | 2020 | Details |
A06989 | 32671089 | Front Nutr | A Description of Risk Factors for Non-alcoholic Fatty Liver Disease in the Southern Community Cohort Study: A Nested Case-Control Study. | 2020 | Details |
A06990 | 32670822 | J Tradit Complement Med | The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease. | 2020 | Details |
A06991 | 32670821 | J Tradit Complement Med | Beneficial effects of Chinese herbs in the treatment of fatty liver diseases. | 2020 | Details |
A06992 | 32670278 | Front Immunol | Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. | 2020 | Details |
A06993 | 32668632 | Int J Mol Sci | Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone? | 2020 | Details |
A06994 | 32668273 | Magn Reson Imaging | Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus. | 2020 | Details |
A06995 | 32667128 | J Diabetes | Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review and meta-analysis. | 2020 | Details |
A06996 | 32666969 | Food Funct | Ameliorative effects and molecular mechanisms of vine tea on western diet-induced NAFLD. | 2020 | Details |